top of page

Serious non-fatal adverse events and reporting rules: veterinary products - Q&A

This questions and answers document was developed to enable all stakeholders understand what constitutes a serious non-fatal adverse event following use of a veterinary medicinal product (VMP), after recommended or non-recommended use.


#RegulatoryAffairsVeterinary #LegislationPharmacovigilance #PharmacovigilanceRiskAssessmentCommittee

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page